SHIP cluster U-turns on Lucentis policy after price is slashed
A primary care trust cluster under the threat of legal action for recommending the use of an unlicensed drug has revoked the policy after the pharmaceutical company cut the price of the medicine.
Continue reading this article – simply subscribe below
Subscribing takes two minutes and you’ll immediately have full access to hsj.co.uk, plus the HSJ magazine delivered every week.
HSJ Subscribers:
If you are a Health Service Journal subscriber please sign in with your email address and click submit:
Not yet a subscriber?
Sign up today for immediate access to hsj.co.uk and Health Service Journal magazine
Find out more about the benefits of a subscription to HSJ by clicking below, or
Alternatively, try our 14-day free trial subscription
